ArticleOncotarget2017

Bortezomib augments lymphocyte stimulatory cytokine signaling in the tumor microenvironment to sustain CD8+T cell antitumor function.

Samuel T Pellom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.